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Background: Macrophages play an important role in neuroinflammatory diseases such as multiple sclerosis (MS)
and spinal cord injury (SCI), being involved in both damage and repair. The divergent effects of macrophages
might be explained by their different activation status: classically activated (CA/M1), pro-inflammatory,
macrophages and alternatively activated (AA/M2), growth promoting, macrophages. Little is known about the
effect of macrophages with these phenotypes in the central nervous system (CNS) and how they influence
pathogenesis. The aim of this study was therefore to determine the characteristics of these phenotypically different
macrophages in the context of the CNS in an in vitro setting.
Results: Here we show that bone marrow derived CA and AA macrophages have a distinct migratory capacity
towards medium conditioned by various cell types of the CNS. AA macrophages were preferentially attracted by
the low weight (< 10 kD) fraction of neuronal conditioned medium, while CA macrophages were attracted in
higher numbers by astrocyte- and oligodendrocyte conditioned medium. Intrinsic motility was twice as high in AA
macrophages compared to CA macrophages. The adhesion to extracellular matrix molecules (ECM) was
significantly enhanced in CA macrophages compared to control and AA macrophages. The actin cytoskeleton was
differentially organized between CA and AA macrophages, possibly due to greater activity of the GTPases RhoA
and Rac in CA macrophages. Phagocytosis of myelin and neuronal fragments was increased in CA macrophages
compared to AA macrophages. The increase in myelin phagocytosis was associated with higher expression of CR3/
MAC-1 in CA macrophages.
Conclusion: In conclusion, since AA macrophages are more motile and are attracted by NCM, they are prone to
migrate towards neurons in the CNS. CA macrophages have a lower motility and a stronger adhesion to ECM. In
neuroinflammatory diseases the restricted migration and motility of CA macrophages might limit lesion size due to
bystander damage.
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Macrophages are phagocytic cells that play an essential
role in both innate and acquired immunity. Macro-
phages are not a homogeneous cell population, since
they are highly plastic cells that are able to respond to a
variety of environmental cues by changing their pheno-
type and physiology [1,2]. The two phenotypes that are
considered to be the most extreme are classically acti-
vated (CA/M1) pro-inflammatory macrophages and
alternatively activated (AA/M2) or growth promoting
macrophages. In tissues, the micro-environment of the
macrophages is thought to determine the phenotype [2].
In vitro, cytokines and other stimuli induce these activa-
tion phenotypes. CA macrophages are induced by inter-
feron-gamma (IFN-g) and lipopolysaccharide (LPS). The
induction of the AA phenotype is not straightforward,
due to the fact that a range of stimuli, such as IL-4/IL-
13, IL-10, immunocomplexes and glucocorticoids, are
reported to induce alternative activation in macrophages
[2]. Consequently, a wide variety of phenotypical and
functional characteristics have been attributed to alter-
natively activated macrophages. The most common and
widely studied way to generate AA macrophages is by
exposure to interleukin (IL)-4/IL-13 [1,3]. Notably, IL-4
stimulated AA and CA macrophages have distinct func-
tions in tissue repair and inflammation. The CA macro-
phages produce nitric oxide (NO) and reactive oxygen
species (ROS) making them cytotoxic [1,4]. Further-
more, they secrete high amounts of pro-inflammatory
cytokines, for example IL-12, that promote inflamma-
tion. Conversely, AA macrophages produce anti-inflam-
matory cytokines, such as IL-10 [1,2], thereby reducing
inflammation. AA macrophages have a higher angio-
genic potential compared to CA macrophages [5]. They
produce growth factors, such as platelet derived growth
factor (PDGF), vascular endothelial growth factor
(VEGF) and fibroblast growth factor (FGF) [5-7]. In
mice, AA macrophages express high levels of arginase.
Due to activation of arginase, arginine is converted to
ornithine, a precursor for collagen, which contributes to
the production of extracellular matrix molecules (ECM)
[8-11] and promotes cell growth [10,12]. Together these
features determine the wound healing and growth pro-
moting phenotype of AA macrophages [1,2].
Macrophages can play crucial roles during neuroin-
flammatory diseases, such as spinal cord injury (SCI)
and multiple sclerosis (MS). MS is a chronic inflamma-
tory disease of the central nervous system (CNS). Major
neuropathological hallmarks of MS are inflammatory
demyelinating lesions associated with perivascular infil-
trates containing macrophages and lymphocytes [13,14].
It is widely accepted that macrophages play an impor-
tant role during MS pathogenesis and both detrimental
and beneficial effects of macrophages have been
observed during MS and experimental autoimmune
encephalomyelitis (EAE), an animal model for MS. Acti-
vated macrophages secrete many products that could
contribute to axonal and oligodendrocyte damage seen
in MS lesions, such as matrix metalloproteinases
(MMPs) [15], NO and glutamate, [16-22]. The elimina-
tion of infiltrating macrophages by clodronate liposomes
suppressed clinical signs of EAE [23,24]. A correlation
was found between location and amount of axonal
damage and loss and cellular infiltrates containing
macrophages [25-27]. These studies suggest that macro-
phages play a detrimental role, but beneficial effects
have been reported for macrophages as well. Phagocyto-
sis of myelin debris is important for axonal repair/
regrowth and remyelination, since myelin components
are known to be growth inhibiting [28,29]. Moreover,
activated macrophages/microglia are found to be
sources of neurotrophins and growth factors, such as
brain derived neurotrophic factor (BDNF) in MS lesions
[30,31] and elimination of infiltrating macrophages
reduced remyelination in demyelinating models [32].
These divergent effects of macrophages have also been
observed during SCI. As with MS, depletion of infiltrat-
ing macrophages was beneficial, indicating that macro-
phages are detrimental. Elimination of infiltrating
macrophages was observed to increase axonal repair and
functional outcome [33-35]. However, macrophages can
also create a growth-permissive environment in which
axonal regeneration can take place during SCI [36-38].
Kigerl et al. observed that CA macrophages predomi-
nate in the SCI lesion, while the AA macrophage
response is only transient in lesions, possibly explaining
limited repair [39].
The divergent effects of macrophages in neuroinflam-
matory diseases might be due to the different activation
states that macrophages can acquire. Little research has
been done on AA and CA macrophages and their func-
tions in the CNS environment. Kigerl et al. found that
conditioned medium from CA macrophages was toxic
to neurons, while conditioned medium from AA macro-
phages was not and could even induce axonal outgrowth
across a gradient of inhibitory substrate [39]. Microglia
activated by IL-4 are able to support oligodendrogenesis
and some neurogenesis from adult neuronal progenitor
cells, indicating a role in CNS repair for these microglia
[40]. Furthermore, in microglia IL-4 induces the expres-
sion of genes typical for alternative activation and IL-4
deficiency in the CNS led to exacerbation of EAE [41].
The aim of the current study was to determine the
functional characteristics of CA and AA macrophages,
with respect to migration, motility, adhesion and phago-
cytosis, in the context of the CNS. We demonstrate for
the first time that CA and AA macrophages behave dif-
ferently under influence of the conditioned media of
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tosis, cytoskeletal functions, varied between CA and AA
macrophages. This was due to variation in cytoskeletal




For neuronal and astrocyte cultures, timed pregnant
C57BL/6 mice were obtained from Charles River (Maas-
tricht, The Netherlands). For isolation of bone marrow,
adult C57BL/6 mice were used from Charles River.
All experiments were performed according to the
guidelines of the local University Committee on Animal
Welfare, which follow the European Communities
Council Directive (86/609/EEC).
Macrophages
Bone marrow derived macrophages were generated as
described previously [42]. Bone marrow was flushed
from femurs and tibias of C57/BL6 mice and cultured
for 1 week in complete macrophage medium (Dulbecco
modified Eagle’s minimal essential medium (DMEM)
(Invitrogen, Breda, the Netherlands) supplemented with
10% fetal calf serum (FCS) (Invitrogen), 15% conditioned
medium from macrophage-colony stimulating factor-
secreting L929 fibroblasts and 2% penicillin/streptomy-
cin-glutamine (Lonza, Breda, the Netherlands) at 37°C.
After 7-10 days in culture adherent cells were approxi-
mately 95% pure macrophages and cells were used for
experiments.
The CA phenotype was induced by exposing macro-
p h a g e sf o r4 8h rt o5×1 0
3 U/ml IFN-g (U-Cytech, the
Netherlands) and 10 ng/ml Escherichia coli LPS (026:B6;
Sigma-Aldrich, Zwijndrecht, the Netherlands) in the cul-
ture medium. AA macrophages were prepared by expo-
sure to 10 ng/ml IL-4 (Invitrogen) in the culture
medium [3,43]. Control macrophages were cultured for
the same period in medium alone.
Macrophages were harvested by 15 min incubation at
37°C with lidocaine (4 mg/ml in PBS; Sigma-Aldrich).
Macrophages were washed and centrifuged for 5 min at
170 g.
The phenotype of the differently activated macro-
phages was determined using a Griess assay and FACS
analysis. Using the Griess assay, nitrite, the stable end
product of NO, was measured. 100 μls u p e r n a t a n to f
the differently activated macrophages was added to 100
μl Griess reagent (0.1% anphthylene diamine dihy-
drochloride, 1% sulfanilamide and 2.5% H3PO4). The
OD540 was measured on a Benchmark microplate
reader (Bio-Rad laboratories, Veenendaal, the Nether-
lands) and the concentration of nitrite present in the
supernatant was determined by linear regression from a
standard curve using known concentrations of sodium
nitrite.
FACS analysis
To determine the expression of several markers on dif-
ferently activated macrophages a FACS analysis was per-
formed. In brief, 1*10
5 macrophages were washed and
incubated with the first antibody (see Table 1) for one
h. Subsequently, macrophages were washed and exposed
to the secondary fluorescently labeled antibody (see
Table 1) for one h. The extent of marker expression was
analysed using flow cytometry (FACSCalibur, Becton
Dickinson, Erembodegem, Belgium) combined with Cell-
quest Pro software (Becton Dickinson). Omission of the
primary antibody was included as negative control. The
mean fluorescent intensity (MFI) of the macrophages
was measured and data of three separate experiments
were averaged. To obtain a better insight into the rela-
tive upregulation of the markers on the differently acti-
vated macrophages the results were expressed relative to
control macrophages.
Conditioned media
Neuron conditioned medium (NCM) was derived from
neurons of C57/BL6 primary mouse CNS. Embryonic
day 19 mouse pups were sacrificed and the brain was
isolated. For neuronal cultures, the cortex was isolated
and incubated with trypsin containing 0.1 mg/ml
DNAse for 15 min at 37°C. The cell suspension was
extensively washed and the neurons were triturated to
create a single cell suspension. Neurons were cultured
in complete neurobasal medium, consisting of incom-
plete neurobasal medium with 1% glutamax, 2% B27
and 0.01% gentamycin (all obtained from Invitrogen), at
a concentration of 1 × 10
5 cells/ml. Beta-tubulin (Cov-
ance, Uden, the Netherlands) staining was performed
and cultures were found to be approximately 90% pure
(data not shown, rest are predominantly astrocytes and
some microglia). After 2 days in culture NCM was
harvested.
For astrocyte conditioned medium (ACM), the fore-
brain cortex of mouse pups was isolated and single cell
suspension was generated. Cells were cultured for 1
week in complete medium which consisted of DMEM
with high glucose, supplemented with 1% glutamax, 10%
FCS and 0.01% gentamycin (all obtained from Invitro-
gen). After 1 week, new medium was added to the cul-
ture. Cultures were characterized using glial fibrillary
acidic protein (GFAP, Sigma-Aldrich) staining and were
found to be approximately 95% pure (rest are neurons
and microglia, data not shown). After 48 hr of culturing,
ACM was harvested.
Oligodendrocyte conditioned medium (OCM) was
harvested during oligodendrocyte development. Primary
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viously [44]. Briefly, oligodendrocyte precursors were
cultured on poly-l-lysine coated cell culture plates for 2
days in a defined SATO medium [45] containing platelet
derived growth factor-AA (PDGF-AA) and fibroblast
growth factor-2 (FGF-2) in order to synchronize precur-
sors to the bipolar oligodendrocyte-type II astrocyte
(O2A) stage. Differentiation was induced by replacing
the growth factors with 0.5% FCS in SATO medium.
Medium was harvested from: (i) cells in the O2A sta-
dium (designated as O2A medium); (ii) cells that had
differentiated from O2A to the galactocerebroside (GC)
stage (3 days differentiation, GC medium); (iii) cells that
differentiated from GC to myelin basic protein (MBP)
positive stage (7 days differentiation, MBP medium);
finally from cells that had developed from MBP to MBP
+ stage (10 days differentiation, designated MBP +
medium).
Fractioning of the conditioned media
I no r d e rt og e ti n s i g h ti n t ot h er a n g eo fm o l e c u l a r
weight of the factors responsible for attraction of macro-
phages, conditioned media were fractioned based on
molecular weight. Aliquots of the conditioned media
were filtered using 10, 50 and 100 K Amicon Ultra cen-
trifugal filter units as described by the manufacturer
(Millipore, Amsterdam, the Netherlands). The aliquots
were first filtered using the 10 kD filter, subsequently 50
and 100 kD, creating three fractions: one containing low
molecular weight (< 10 kD), one with intermediate
molecular weight (between 10 and 50 kD) and a fraction
from 50 to 100 kD. The fractions were reconstituted in
half of the original volume.
Migration and motility
The migratory capacity of CA and AA macrophages was
studied using a 48-wells micro chemotaxis chamber
(Neuro Probe, Gaithersburg, USA) as described pre-
viously [46] with some modifications. In the bottom
well, 25 μl of the conditioned media, control medium
(neurobasal for NCM, DMEM for ACM and SATO
medium for OCM), monocyte chemotactic peptide-1
(MCP-1) (20 ng/ml; Peprotech inc, London, UK) or for-
myl methionineleucyl-phenylalanine (fMLP) (10 nM;
Sigma-Aldrich) was added. A f i l t e rw i t hap o r es i z eo f
10 μm was used. In the upper chamber 2 *10
4 differ-
ently activated macrophages were added. The macro-
phages were left to migrate for 6 h. The side of the filter
in direct contact with the upper chamber was washed
and scraped clean of cells and the filter was subse-
quently stained using Coommassie Blue. The number of
migrated cells was counted per 0.1 mm
2 using a scored
eyepiece. From this the total number of migrated cells
was calculated.
To determine motility, 5*10
4 CA and AA macro-
phages were seeded in culture plastic 96 wells plate
(Greiner Bio One, Alphen a/d Rijn, the Netherlands)
and cultured for 1 h. The 96-wells plate was placed in a
time-lapse video microscope. Macrophages in each well
were followed for 15 min and images were taken every
20 seconds at a 40 times magnification. The software
program Track-It
® was used to calculate speed and dis-
tance moved as a measure for motility. All the cells pre-
sent in a microscopic field were tracked manually.
Adhesion
Macrophage adhesion to plastic and several extracellular
matrix molecules (ECM) was determined as described
previously [47]. CA and AA macrophages were harvested
and labeled with 1 μM BCECF-AM (Invitrogen) for 15
min at 37°C. After labeling, cells were washed and 1 ×
10
5 macrophages in 100 μl were seeded in the 96 wells
plates. Macrophages were left to adhere for 2 h at 37°C
and 5% CO2. After incubation, non-adherent cells were
removed by washing 3 times in PBS and the remaining
adherent cells were lysed with 0.1 N NaOH. Fluorescence
was measured in a Fluostar24 (BMG labtechnologies,
Offenburg, Germany). A standard curve with cell concen-
trations ranging from 5 × 10
3 to 1 × 10
6 cells/ml was
made to determine the percentage of adhering cells.
Table 1 Antibodies and dilutions used in FACS analysis of macrophages
Primary antibody Subtype Dilution Secondary antibody Dilution
F4/80 (Serotec, Oxford, UK) IgG 1:500 Anti-rat Alexa 488
(Invitrogen)
1:400
MAC-1 (Serotec, Oxford, UK) IgG 1:500 Anti-rat Alexa-488
(Invitrogen)
1:400
MR biotinylated (Biolegend, Uithoorn, the Netherlands) IgG 1:100 Streptavidin-Alexa 488
(Invitrogen)
1:400
LFA-1 produced in house IgG 1:250 Anti-rat Alexa 488
(Invitrogen)
1:400
CD29 (BD Pharmingen, Breda, the Netherlands) IgG 1:100 Anti-rat Alexa 488
(Invitrogen)
1:400
CD11a-FITC (eBioscience, Malden, the Netherlands) IgG 1:100
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macrophages to different ECM molecules, wells of a
96-well culture plate were coated with either collagen
(type I from calf skin, Sigma-Aldrich), for 1 h at room
temperature, or fibronectin (derived from human plasma;
Roche, Almere, the Netherlands), for 1 h at 37°C.
We investigated the expression of adhesion receptors
on differently activated macrophages using FACS analy-
sis. We performed the FACS analysis as described
above. The antibodies used are listed in Table 1.
Actin cytoskeleton
The actin cytoskeleton of the differently activated
macrophages was visualized using rhodamine phalloidin
(Invitrogen). Macrophages were cultured on glass cover-
slips and stimulated in order to generate the different
phenotypes. After 2 days, macrophages were fixed by
incubation for 30 min with paraformaldehyde (4% in
PBS). The macrophages were washed twice with PBS
containing 0.1% Tween-20 (Sigma-Aldrich) and exposed
to rhodamine phalloidin (1:300, Sigma-Aldrich) in PBS
containing 0.1% Tween-20 for 1 h. To visualize nuclei,
the cells were counterstained with Hoechst (Invitrogen)
and afterwards embedded in mounting medium.
RhoA and Rac activity G-LISA
RhoA and Rac activity in differently activated macro-
phages was determined using G-LISA activation assay
kit (Cytoskeleton, Denver, USA) according to the manu-
facturer’s description. In brief, macrophage cell lysate
was added to a pre-coated 96-wells plate to which the
active, GTP-bound form of the protein will bind. The
bound protein was detected using a primary antibody to
the protein and a secondary antibody linked to HRP.
The signal was developed using OPD and absorbance
was measured using a Benchmark microplate reader
(Bio-Rad laboratories, Veenendaal, the Netherlands).
Phagocytosis
The extent of phagocytosis of fluorescently labeled mye-
lin and neuronal fragments by macrophages was deter-
mined using fluorescence activated cell sorter (FACS)
analysis. Neuronal fragments were made by roughly
pipetting 2 day old neuronal cultures, prepared as
described previously [48], and labeling them with the
lipophilic fluorescent dye 1,1’,di-octadecyl-3,3,3’3’-tetra-
methylindocarbocyanine perchlorate (DiI) (Sigma-




5 Macrophages were washed twice and incubated
with fluorescently labeled myelin (10 or 20 μg/ml) for
1.5 h at 37°C. Macrophages were washed three times
and harvested using 4 mg/ml lidocain (Sigma-Aldrich)
for 15 min at 37°C. The macrophages were washed and
analyzed using flow cytometry and Cellquest Pro soft-
ware. Phagocytosis was displayed in percentages relative
to control macrophages.
To determine the effect of CR3, small GTPases and
ROS on phagocytosis, anti-CR3 antibody (10 μg/ml),
quercetin (300 μM, Kaden Biochemicals, Hamburg, Ger-
many), luteolin (300 μM, Kaden Biochemicals) and
diphenylene iodonium (DPI) (Sigma-Aldrich) were
added to macrophages during the phagocytosis.
To exclude that the phagocytosis measured on the
FACS is only binding, confocal images were taken of
macrophages after phagocytosis. Macrophages were cul-
tured and stimulated for 48 h with either IFN-g and LPS
or IL-4 to generate the different phenotypes on cover
slip glasses. The macrophages were incubated with DiI
labeled myelin or neuronal fragments for 1.5 h at 37°C.
Afterwards, the macrophages were stained using MAC-1
and the Alexa 488 labeled anti-rat secondary antibody.
Images were taken on a Leica TCS SP2 confocal
microscope.
Statistical analysis
The data are expressed as mean of 3 to 4 separate
experiments performed in duplo (± SEM). Statistics
were performed in SPSS (15.0.0, Chicago, USA). The
motility, migration, adhesion, G-LISA and phagocytosis
experiments were analysed using one-way ANOVA with




The phenotype of the differently activated macrophages
was determined by investigating both marker expression
and NO production. The expression of Mac-1, F4/80
and MR was determined using FACS analysis. MR is a
longstanding marker for the AA phenotype [3]. Macro-
phages stimulated in vitro with IFN-g and LPS have
been found to express high levels of Mac-1 [49]. In
accordance with literature, we observed a significant
upregulation of the immunoreactivity for Mac-1 and F4/
80 on CA macrophages, while the immunoreactivity for
MR was increased on AA macrophages (Figure 1A).
CA macrophages are known to produce NO and ROS.
Therefore, the production of NO was taken as a marker
for the CA phenotype. Significant amounts of NO were
produced by CA macrophages, while no detectable
amounts of NO were produced by AA and control
macrophages (Figure 1B).
CA and AA macrophages migrate differently towards
conditioned media from CNS cells
To investigate whether CA and AA macrophages
migrate towards different CNS cell types, a 48-wells
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migrated over a filter in response to conditioned med-
ium harvested from neurons, astrocytes and several
developmental stages of oligodendrocytes.
AA macrophages migrated in significantly higher num-
bers towards NCM compared to control neurobasal med-
ium. CA macrophages were not attracted towards NCM
(Figure 2A). In order to determine the molecular weight
range of the factors that act chemotactic on AA macro-
phages, NCM was fractioned according to molecular
weight. The NCM fraction containing proteins smaller
than 10 kD was responsible for this effect (Figure 2B).
In contrast, migration of CA macrophages was signifi-
cantly enhanced towards ACM compared to control
medium (Figure 2C). The ACM fraction containing
molecules smaller than 10 kD was responsible for the
attraction of CA macrophages (Figure 2D). Fractions
containing proteins larger than 10 kD did not signifi-
cantly attract macrophages. AA macrophages did not
migrate in higher numbers towards ACM compared to
control medium.
The conditioned media of different stages of oligoden-
drocyte development, from precursors to mature oligo-
dendrocytes, significantly attracted CA and AA
macrophages compared to the control medium (Figure
2E). Control macrophages migrated in significantly
higher numbers towards the GC and MBP developmen-
tal stages compared to control medium. Specifically the
GC developmental stage induced enhanced migration in
all macrophage phenotypes. CA macrophages were
attracted in significantly higher numbers compared to
both control and AA macrophages.
AA macrophages have a higher motility than CA
macrophages
Since we observed this striking effect on migration, we
next determined the motility of CA and AA macrophages
using a time-lapse video microscope. AA macrophages
were significantly more motile compared to CA macro-
phages (Figure 3A and 3B). CA macrophages appeared to
move very little.
Since motility was lower in CA macrophages com-
pared to AA macrophages, we wanted to determine
whether the intrinsic migratory capacity of CA macro-
phages was also reduced. Migration towards the potent
macrophage attractors MCP-1 and fMLP, a synthetic
analogue of a bacterial signal peptide, was used to
address this question. As can be seen in Figure 3C, AA
and CA macrophages migrated in comparable numbers
towards fMLP and MCP-1, indicating that the intrinsic
migratory capacity did not differ.
We next investigated whether the difference in moti-
lity was related to altered adherence. Therefore, the
adhesion capacity of the differently activated macro-
phages to culture plastic and ECM molecules was mea-
sured. On culture plates CA macrophages displayed a
trend towards increased adherence compared to control
and AA macrophages (Figure 3D). After coating the cul-
ture plates with either collagen or fibronectin, the per-
centage of CA macrophages that adhered was enhanced
twofold compared to both control and AA macrophages.
We next investigated whether altered presence of adhe-
sion receptors could explain the differences in adher-
ence seen. We determined the expression of MAC-1,
lymphocyte function associated antigen-1 (LFA-1),
Figure 1 Analysis of macrophage phenotype. A) Using FACS analysis the expression of markers for the differently activated phenotype was
determined. CA macrophages expressed significantly more MAC-1 and F4/80 compared to AA and control macrophages. MR expression was
significantly higher on AA macrophages compared to control and CA macrophages. B) NO production was undetectable in both control and AA
macrophages. CA macrophages did produce NO.
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from various CNS cell types and chemokines by in vitro stimulated bone marrow derived macrophages was studied using a 48-wells micro
chemotaxis chamber. The data are expressed as the mean of 4 separate experiments (n = 4) ± SEM. A) AA macrophages migrate in significantly
higher numbers towards NCM compared to control medium, 191 and 77 respectively and also compared to CA macrophages, 57. * = p < 0.05.
B) AA macrophages migrated in significantly higher numbers towards the fraction of the NCM containing proteins smaller than 10 kD compared
to CA macrophages. Both the fractions containing proteins smaller than 10 kD and between 10 and 50 kD significantly enhanced migration of
AA macrophages compared to control medium. * = p < 0.05. C) CA macrophages migrate in significantly higher numbers towards ACM
compared to control medium, 92 and 59 macrophages respectively. AA macrophages did not specifically migrate towards ACM. No difference
was seen in the number of migrated macrophages towards ACM between CA and AA macrophages. * = p < 0.05. D) The fraction of the ACM
containing proteins smaller than 10 kD significantly enhanced the migration of CA macrophages compared to control medium and AA
macrophages. * = p < 0.05. E) The different stages of oligodendrocyte development conditioned medium significantly enhanced migration of
both CA and AA macrophages compared to oligodendrocyte control medium, however CA macrophages migrated in significantly higher
numbers compared to AA and control macrophages. * = p < 0.05 is significantly different from control medium; # is p < 0.05 different from AA
and control macrophages.
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cantly more adhesion receptors compared to both con-
trol and AA macrophages (Figure 3E).
Actin cytoskeleton of CA and AA macrophages
Migration, motility and adhesion are functions that are
all linked to the cytoskeletal organization of cells. There-
fore we determined whether differences in the cytoskele-
ton could be observed between the macrophage
phenotypes, by staining both phenotyopes for F-actin
(Figure 4A-C). Remarkably, the morphology of CA
macrophages appeared more rounded with an enhanced
number of lamellipodia compared to control macro-
phages. In contrast, AA macrophages were elongated
compared to control cells. In CA macrophages the
staining pattern showed clustering of F-actin around the
nucleus, whereas in AA macrophages the staining was
more prominent at the border of the cell, indicating
possible focal adhesions.
Next we determined the activity of small GTPases
RhoA and Ras in activated macrophages, since they are
involved in actin cytoskeleton modulation. The activity
Figure 3 Motility and migratory capacity. Motility of in vitro stimulated bone marrow derived macrophages was determined by timelapse
video microscopy. Speed and distance covered were determined using TrackIt software. The migration towards fMLP and MCP-1 was used as a
measure for migratory capacity of in vitro stimulated bone marrow derived macrophages. Adhesion was determined by plating fluorescently
labeled macrophages on (un)coated 96 wells plates, washing the plates after 2 h and measuring fluorescence. Data are the mean of 3 separate
experiments (n = 3) ± SEM. *= p < 0.05. A) During the recorded time the average distance AA macrophages covered was significantly enhanced
twofold compared to CA macrophages. The distance was recorded in μm. B) AA macrophages had a twofold higher speed compared to CA
macrophages. Speed was recorded in μm/sec. C) No difference in migration was seen between the different macrophage phenotypes when
comparing migration towards either fMLP or MCP-1. D) CA macrophages displayed a trend towards higher adherence on plastic compared to
control and AA macrophages. On fibronectin and collagen adherence of CA macrophages was twofold higher compared to both control and
AA macrophages. E) The expression of adhesion receptors was higher in CA macrophages compared to both AA and control macrophages.
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macrophages compared to both control and AA macro-
phages (Figure 4D).
Phagocytosis of myelin is higher in CA compared to AA
macrophages
Phagocytosis, a crucial macrophage function, is also
linked to the activity of small GTPases and cytoskeletal
reorganisation. We determined the myelin phagocytosis
capacity of the differently activated macrophages.
CA macrophages had a significant twofold increase in
the phagocytosis of myelin compared to both control
and AA macrophages (Figure 5A). In order to ensure
that phagocytosis had taken place, we showed internali-
zation of myelin by confocal microscopy (Figure 5 B-D).
DiI labeled myelin was visible within the green labeled
membranes of macrophages, showing that phagocytosis
of myelin had indeed taken place. Since Mac-1, also
called CR3, has been shown to be involved in myelin
phagocytosis [50] and we observed a significantly higher
expression of Mac-1 by CA macrophages compared to
both control and AA macrophages (Figure 1A and 3E)
we determined whether phagocytosis of myelin could be
blocked using anti-CR3 antibodies. Myelin phagocytosis
could be blocked using anti-CR3 antibodies in CA
macrophages and control macrophages. The block of
myelin phagocytosis by anti-CR3 antibodies in AA
macrophages was not significant (Figure 5B).
Next to CR3, ROS have also been implicated in the
induction of phagocytosis. We therefore tested the effect a
specific NADPH oxidase inhibitor, diphenylene iodonium
(DPI), on myelin phagocytosis. Blocking ROS production,
by DPI, reduced myelin phagocytosis by control and AA
macrophages significantly (Figure 6). However, exposure
to DPI did not have a significant effect on myelin phagocy-
tosis by CA macrophages (Figure 6). Finally, flavonoids
were used to block phagocytosis, since flavonoids are able
to influence phagocytosis at multiple levels, such as ROS
production and cytoskeleton mobilization. Using quercetin
and luteolin, phagocytosis of myelin by CA, AA and con-
trol macrophages was blocked (Figure 6).
Phagocytosis of neuronal fragments is higher in CA
compared to AA macrophages
During neuroinflammatory diseases not only myelin
debris is present, but also neuronal debris. Phagocytosis
of myelin is well investigated, which is not the case for
neuronal debris. Indications that neuronal debris is pha-
gocytosed, comes from MS research. Macrophages were
suggested to transport neuronal debris outside the CNS,
Figure 4 Cytoskeleton of differently activated macrophages. A-C) Visualization of actin cytoskeleton, red: actin (rhodamine phalloidin); blue:
nuclear staining (Hoechst). Representative pictures are shown. CA macrophages appear flattened and rounded. AA macrophages are more
stretched and elongated. Control macrophages appear to possess morphology in between the two extremes, with some cells being more
elongated while others are more rounded. The scale bar is 50 μm and a 40 times magnification was used. D) Rac and Rho activity. In CA
macrophages small GTPases are more activated compared to both control and AA macrophages.
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patients contained neuronal antigens [51]. Therefore, we
investigated the phagocytosis of neuronal fragments,
obtained by roughly pipetting a monolayer of neurons
as a model for neuronal debris, by differently activated
macrophages.
Phagocytosis of neuronal fragments was significantly
enhanced by CA macrophages compared to both control
and AA macrophages (Figure 7A). The phagocytosis of
neuronal fragments did not differ between control and
AA macrophages. To ensure that phagocytosis had
taken place, we investigated internalization of neuronal
fragments by confocal microscopy (Figure 7 B-D). All
macrophage phenotypes were able to phagocytose
neuronal fragments, since red labeled neuronal frag-
ments were present within green labeled membranes.
Some binding of neuronal fragments outside the macro-
phage membrane was also visible. The phagocytosis of
neuronal fragments could be significantly blocked using
luteolin and quercetin in all macrophage subtypes (Fig-
ure 7E). MAC-1 did not reduce phagocytosis of neuro-
nal fragments. DPI only reduced phagocytosis in control
macrophages.
Discussion
In this study we focused on functional consequences of
differential activation of macrophages for cytoskeleton-
associated functions as migration, motility, adhesion and
Figure 5 Phagocytosis of myelin by differently activated macrophages. Phagocytosis of fluorescently labeled myelin by activated bone
marrow derived macrophages and expression of CR3 was determined using flow cytometry. MFI was measured and data are the mean of 4
separate experiments (n = 4) ± SEM. *= p < 0.05 and #= p < 0.05. A) CA macrophages phagocytosed significantly more myelin compared to
control and AA macrophages. B-D) Visualization of myelin internalization by phagocytosis, red: DiI labeled myelin; green: Mac-1 on macrophage
membrane. Representative images, taken on a confocal microscope, are shown. Red myelin is seen inside the green labeled membrane of the
differently activated macrophages. All macrophage phenotypes appear to have taken up myelin. A 20 times magnification was used. E) Using
anti-MAC-1 antibody, phagocytosis of myelin by CA and control macrophages could be blocked significantly, as indicated by #. Anti-MAC-1
antibody did not affect myelin phagocytosis by AA macrophages.
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Page 10 of 16phagocytosis in the CNS. These properties may have
considerable impact on the local effects of macrophage
subtypes during neuroinflammation. We observe that
different CNS cell types have diverging effects on the
migration of CA and AA macrophages. Furthermore we
show that activation status affects motility, adhesion and
phagocytosis of differently activated macrophages.
Finally, the actin cytoskeleton appeared differently orga-
nized between CA and AA macrophages.
This study shows that AA and CA macrophages differ
in the CNS cell types towards which they migrate. AA
macrophages were significantly attracted towards NCM.
Especially small proteins, < 10 kD, were responsible for
the preferential attraction of CA versus AA macro-
phages, suggesting that chemokines could be responsible
for this effect. Interestingly, human AA macrophages
have increased expression levels of CXCR4, the receptor
for CXCL12 which is expressed in cultured neurons [52]
and in normal brain [53], while CA macrophages have
higher expression levels of CCR7 [54]. Furthermore, the
migration towards the < 10 kD fraction of the medium
induced a higher migration in AA macrophages com-
pared to the whole medium, indicating that molecules
present in the higher molecular weight fractions could
be inhibiting migration. We observed that murine CA
macrophages were significantly attracted towards ACM
and oligodendrocyte conditioned medium. Using ACM,
small proteins, < 10 kD, in the conditioned media
attracted macrophages, suggesting that astrocytes release
cytokines or chemokines. Again the lower molecular
weight fraction of the medium induced a higher migra-
tion in CA macrophages compared to the complete
medium, indicating the presence of inhibitory molecules
in the whole medium. Finally, OCM, specifically of the
GC developmental stage, attracted macrophages to a
much higher extent compared to both NCM and ACM.
The cells in the GC developmental stage are differentiat-
ing oligodendrocyte precursors. In vivo, macrophages
are found both in areas of demyelination as well as in
areas of remyelination. Furthermore, remyelination cor-
related with the number of oligodendrocytes and macro-
phages [55,56]. The fact that the OCM was derived from
rat oligodendrocytes and the macrophages used for
migration were murine could also play a role in the
migration. Since in humans little research has been per-
formed on differently activated macrophages within the
CNS, no clinical data is available on the preferential
association of differently activated macrophages with
specific CNS cell types in human pathology.
Our results showed that the differences in migration
were not due to intrinsic differences in migratory capa-
city, since fMLP and MCP-1 attracted both types of
macrophages in comparable levels. Both fMLP and
MCP-1 are potent chemoattractants [57,58]. Subtle dif-
ferences in chemoattraction, due to differences in che-
mokine receptor expression, might be masked due to
the high potency of these molecules.
One caveat in our study is that we used the superna-
tant of resting cultures to determine chemoattraction,
which does not resemble the neuroinflammatory CNS.
The cells in the inflamed CNS might secrete factors that
were not present in our study, possibly changing the
chemoattraction of the CA and AA macrophages. Dur-
ing EAE and MS, MCP-1 expression is upregulated in
the CNS and in EAE a close association was observed
between increased expression of MCP-1 and relapses
Figure 6 Influence of DPI and flavonoids on phagocytosis of myelin. To determine the influence of DPI, a NADPH oxidase blocker, and
flavonoids on myelin phagocytosis, these substances were added together with fluorescently labeled myelin. Phagocytosis is determined as MFI
of the macrophages. Data are the mean of 4 separate experiments (n = 4) ± SEM. *= p < 0.05. Both luteolin and quercetin significantly blocked
phagocytosis of myelin by control, CA and AA macrophages. DPI only significantly reduced phagocytosis of myelin by control and AA
macrophages. DPI did not significantly decrease phagocytosis of myelin by CA macrophages.
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astrocytes and macrophages [60,61]. Since MCP-1
attracted all subtypes of macrophages equally, this
would indicate that in MS lesions all macrophage sub-
types would be able to migrate equally towards these
reactive astrocytes, since no differences were observed
in migration towards MCP-1.
Although the intrinsic migratory capacity, determined
using fMLP and MCP-1, did not differ between CA and
AA macrophages, we observed significantly higher spon-
taneous motility in AA macrophages compared to CA
macrophages. An important factor for motility is the
adhesive capacity of macrophages. Adhesion can also be
influenced by the cytoskeletal organization [62,63]. We
showed that CA macrophages adhered to a higher
extent to culture plates and ECM molecules compared
to AA macrophages, confirming that adhesion might
also have an impact on the increased motility and
migration towards NCM of AA macrophages. Our find-
ings were in line with a previous study, observing that
glucocorticoid stimulated murine monocytes, which dis-
play some features of AA macrophages, adhered less
a n dw e r em o r em o t i l et h a nc o n t r o lc e l l s[ 6 4 ] .W e
observed enhanced expression adhesion receptors in CA
macrophages. Lymphocyte function associated antigen-1
(LFA-1), MAC1 (CR3), CD29 and CD11a expression
Figure 7 Phagocytosis of neuronal fragments by differently activated macrophages. Phagocytosis of fluorescently labeled neuronal
fragments by activated bone marrow derived macrophages was determined using flow cytometry. Phagocytosis was blocked using anti-MAC-1
antibodies, luteolin, quercetin and DPI. Data are the mean of 4 separate experiments (n = 4) ± SEM. *= p < 0.05 and #= p < 0.05. A) CA
macrophages phagocytosed significantly more neuronal fragments compared to control and AA macrophages. B-D) Visualization of neuronal
fragment internalization by phagocytosis, red: DiI labeled neuronal fragments; green: Mac-1 on macrophage membrane. Representative images,
taken on a confocal microscope (Leica TCS SP2), are shown. Red labelled neuronal fragments are clearly present within the green labelled
membrane of the differently activated macrophages. Some binding is also present, with the neuronal fragments being present outside the
membrane. A 20 times magnification was used. E) To determine whether phagocytosis could be blocked macrophages were exposed to
luteolin, quercetin, MAC-1 (anti-CR3 antibody) or DPI (NADPH oxidase blocker). Phagocytosis of neuronal fragments by all types of macrophages
was significantly reduced by exposure to luteolin and quercetin. Using MAC-1 antibody did not reduce neuronal fragment phagocytosis. DPI led
to a significant reduction in control macrophages, however, CA and AA macrophages did not reduce phagocytosis significantly.
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phages. The increased expres s i o no fa d h e s i o nr e c e p t o r s
in macrophages stimulated with IFN-g and LPS is in
line with previous studies [49,65] and with our current
finding that CA macrophages adhere better when com-
pared to AA macrophages.
We observed that AA macrophages were more elon-
gated, whereas CA macrophages were rounded. This is
in line with findings in human M1 and M2 macro-
phages. Human M2 macrophages, analogous to AA
macrophages, appeared stretched with a spindle-like
morphology, while human M1, analogous to CA macro-
phages, macrophages appeared rounder with a “fried-
egg” morphology [66]. The cytoskeletal organization dif-
fered between AA and CA macrophages, in that we
found clusters of actin around the nucleus in CA
macrophages, while the actin cytoskeleton of AA macro-
phages was more prominent at the border of the cell.
Rho and Rac activity was higher in CA macrophages
compared to both control and AA macrophages, possi-
bly underlying the differences seen in cytoskeletal orga-
nization. These results indicate that during the
transition to the AA phenotype macrophages become
increasingly stretched and motile allowing migration
into tissues, while transition to the CA phenotype leads
to decreased motility and a round morphology, probably
limiting migration.
Phagocytosis of myelin was higher in CA versus AA
and control macrophages. We wanted to determine the
mechanism behind this difference. CR3 is implicated in
myelin phagocytosis [67]. We found a significantly higher
expression of CR3, also called MAC-1, on CA macro-
phages compared to AA macrophages. This is in line
with previous data showing upregulation of CR3 after
IFN-g and LPS treatment of macrophages [49]. Myelin
phagocytosis by CA macrophages could be blocked using
anti-CR3 antibodies. A slight reduction in myelin phago-
cytosis was seen after exposure of AA macrophages to
anti-CR3 antibodies. These results indicate that CR3
plays an important role in myelin phagocytosis by both
control and CA macrophages, while in AA macrophages
another mechanism of phagocytosis is dominant. Next to
the phagocytosis of myelin, the CA macrophages also
phagocytosed significantly more neuronal fragments
compared to control and AA macrophages. CR3 is not
involved in the phagocytosis of neuronal fragments, since
addition of anti-CR3 antibodies did not reduce phagocy-
tosis by any of the macrophage subtypes.
In rat macrophages myelin phagocytosis was ROS
dependent [68]. Blocking ROS production by treatment
with DPI blocked phagocytosis of myelin by AA and
control macrophages, suggesting that ROS play an
important role in myelin phagocytosis in these macro-
phages. The effect on CA macrophages was not
significant, indicating that ROS do not play a significant
role here. This could be due to the fact that myelin pha-
gocytosis is CR-3 mediated in CA macrophages, while
this does not seem to play a major role in either AA or
control macrophages. Phagocytosis of neuronal frag-
ments was reduced by DPI only in control macrophages,
indicating an important role for ROS in control macro-
phage phagocytosis. Both CA and AA macrophages did
not reduce phagocytosis of neuronal fragments after
exposure to DPI, suggesting a specific mode of uptake
similar to myelin uptake by CA macrophages via CR3.
The flavonoids quercetin and luteolin significantly
reduced macrophage phagocytosis of both myelin and
neuronal fragments by all types of macrophages. Pre-
viously, myelin phagocytosis was blocked after exposure
to quercetin and luteolin in a macrophage cell line [69].
Quercetin and luteolin have anti-oxidant properties [69],
suggesting that scavenging of ROS is an important fac-
tor in phagocytosis. Furthermore, they inhibit nuclear
factor-kappa B, thereby inhibiting pro-inflammatory
cytokine secretion and NO production [70,71]. However,
flavonoids do more than scavenge. Quercetin could also
mediate its effects due to the inhibition of protein tyro-
sine kinases, which are involved in the signaling of the
engulfment phase of CR3 mediated phagocytosis [72].
Luteolin has effects on the actin cytoskeleton [73,74]
through Rho and Rac [75] and could thereby affect
phagocytosis.
In conclusion, the neuronal damage that occurs dur-
ing neuroinflammatory diseases, such as MS, seems to
be correlated to clinical disability [27,76]. CA macro-
phages have a lower ability to migrate, since they adhere
strongly to the ECM and are generally less motile, limit-
ing the amount of bystander damage due to ROS and
NO secreted by the CA macrophages. Altogether this
would contribute to a limited lesion expansion. Due to
the fact that AA macrophages are more motile, adhere
less to the ECM and are attracted by NCM, they could
migrate towards neurons and locally release growth fac-
tors where they are most needed. AA macrophages are
considered to be growth promoting and can secrete
neurotrophic factors [30]. Therefore, skewing macro-
phages towards an AA phenotype could be a novel ave-
nue for the development of new therapeutic strategies in
neuroinflammatory diseases. Several studies have found
therapeutic effects of AA macrophages. In vitro gener-
ated AA macrophages reduced renal and pancreatic
injury in a model for murine diabetes [77]. In a model
for colitis the injection of AA macrophages ameliorated
the disease [78]. In spinal cord injury addition of multi-
potent adult progenitor cells reduced axonal dieback
induced by macrophages [79]. In vitro these multipotent
adult progenitor cells induced an AA phenotype in
macrophages [79]. Treatment with anti-CCL22 [80] and
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macrophages to an alternatively activated phenotype,
increased the presence of AA macrophages in the
lesions and ameliorated EAE disease course. Administra-
tion of AA macrophages reduced the development of
relapses during the relapsing EAE model [82]. Adoptive
transfer of AA macrophages induced using glatiramer
acetate reversed clinical EAE [83]. Finally, in MS
patients a deficiency in negative regulation of macro-
phage activation by Src homology region 2 domain-con-
taining phosphatase-1 (SHP-1) was observed, leading to
an enhanced response of these macrophages to both
LPS and IL-4 [84,85]. This indicates that lesion environ-
ment determines the activation status of macrophages.
Similar results have been found in a mouse model of
Alzheimer’s disease, since mRNA levels for markers of
the CA and AA phenotype were observed to be upregu-
lated in microglial cells, indicating that these microglia
express functional characteristics of both CA and AA
macrophages [86]. Together with the data from our cur-
rent study, this supports the hypothesis that the “set-
ting” of the innate immune system is crucial for disease
outcome in inflammatory diseases of the CNS such as
MS and SCI.
List of abbreviations
AA: alternatively activated; ACM: astrocyte conditioned medium; CA:
classically activated; CNS: central nervous system; CR3: complement receptor
3; DMEM: Dulbecco modified Eagle’s minimal essential medium; DiI: 1,1’,di-
octadecyl-3,3,3’3’-tetramethylindocarbocyanine perchlorate; DPI: diphenylene
iodonium; EAE: experimental autoimmune encephalomyelitis; ECM:
extracellular matrix; FCS: foetal calf serum; fMLP: formyl methionineleucyl-
phenylalanine; GAP-43: growth associated protein 43; GFAP: glial fibrillary
acidic protein; IFN-γ: interferon-gamma; IL: interleukin; iNOS: inducible nitric
oxide synthetase; IR: immunoreactivity; LFA-1: lymphocyte function
associated antigen-1; LPS: lipopolysaccharide; MBP: myelin basic protein;
MCP-1: monocyte chemotactic peptide-1; MMP: matrix metalloproteinase;
MR: mannose receptor; MS: multiple sclerosis; NADPH-oxidase: nicotinamide
adenine dinucleotide phosphate-oxidase; NCM: neuronally conditioned
medium; NF: neurofilament; NO: nitric oxide; OPC: oligodendrocyte precursor
cell; PBS: phosphate buffered saline; ROS: reactive oxygen species; SCI: spinal
cord injury
Acknowledgements
We would like to thank B. Beürger for providing mice and Martina Moeton
and Ansam Barakat for technical assistance. This work was supported by the
Dutch MS Research Foundation, grant number: 05-358c. Dutch Research
Council (NWO (016.056.024)).
Author details
1Department of Molecular Cell Biology and Immunology, VU University
Medical Center, Amsterdam, the Netherlands.
2University Medical Center
Groningen University of Groningen, Dept. Cell Biology, Section Membrane
Cell Biology, Groningen, the Netherlands.
3Department of Clinical chemistry,
VU University Medical Center, Amsterdam, the Netherlands.
Authors’ contributions
EV was involved in data acquisition, data analysis and statistical analysis. EV
drafted the manuscript. DH performed the phagocytosis and FACS analysis
assays. WB contributed the oligodendrocyte conditioned medium and
critically reviewed the manuscript. HdV participated in the data analysis and
conceptualization. CD and CT participated in study design,
conceptualization, data analysis and helped to draft the manuscript. All
authors have read and approved the final version of the manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 17 February 2011 Accepted: 26 May 2011
Published: 26 May 2011
References
1. Edwards JP, Zhang X, Frauwirth KA, Mosser DM: Biochemical and
functional characterization of three activated macrophage populations. J
Leukoc Biol 2006, 80:1298-1307.
2. Mosser DM, Edwards JP: Exploring the full spectrum of macrophage
activation. Nat Rev Immunol 2008, 8:958-969.
3. Stein M, Keshav S, Harris N, Gordon S: Interleukin 4 potently enhances
murine macrophage mannose receptor activity: a marker of alternative
immunologic macrophage activation. J Exp Med 1992, 176:287-292.
4. Nathan C, Shiloh MU: Reactive oxygen and nitrogen intermediates in the
relationship between mammalian hosts and microbial pathogens. Proc
Natl Acad Sci USA 2000, 97:8841-8848.
5. Kodelja V, Muller C, Tenorio S, Schebesch C, Orfanos CE, Goerdt S:
Differences in angiogenic potential of classically vs alternatively
activated macrophages. Immunobiology 1997, 197:478-493.
6. Mantovani A, Sica A, Allavena P, Garlanda C, Locati M: Tumor-associated
macrophages and the related myeloid-derived suppressor cells as a
paradigm of the diversity of macrophage activation. Hum Immunol 2009,
70:325-330.
7. Song E, Ouyang N, Horbelt M, Antus B, Wang M, Exton MS: Influence of
alternatively and classically activated macrophages on fibrogenic
activities of human fibroblasts. Cell Immunol 2000, 204:19-28.
8. Kreider T, Anthony RM, Urban JF, Gause WC: Alternatively activated
macrophages in helminth infections. Curr Opin Immunol 2007, 19:448-453.
9. Albina JE, Mills CD, Henry WL, Caldwell MD: Temporal expression of
different pathways of 1-arginine metabolism in healing wounds. J
Immunol 1990, 144:3877-3880.
10. Gratchev A, Guillot P, Hakiy N, Politz O, Orfanos CE, Schledzewski K,
Goerdt S: Alternatively activated macrophages differentially express
fibronectin and its splice variants and the extracellular matrix protein
betaIG-H3. Scand J Immunol 2001, 53:386-392.
11. Hesse M, Modolell M, La Flamme AC, Schito M, Fuentes JM, Cheever AW,
Pearce EJ, Wynn TA: Differential regulation of nitric oxide synthase-2 and
arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology
is shaped by the pattern of L-arginine metabolism. J Immunol 2001,
167:6533-6544.
12. Modolell M, Corraliza IM, Link F, Soler G, Eichmann K: Reciprocal regulation
of the nitric oxide synthase/arginase balance in mouse bone marrow-
derived macrophages by TH1 and TH2 cytokines. Eur J Immunol 1995,
25:1101-1104.
13. Lassmann H, Bruck W, Lucchinetti C, Rodriguez M: Remyelination in
multiple sclerosis. Mult Scler 1997, 3:133-136.
14. van der Valk, De Groot CJ: Staging of multiple sclerosis (MS) lesions:
pathology of the time frame of MS. Neuropathol Appl Neurobiol 2000,
26:2-10.
15. Cuzner ML, Gveric D, Strand C, Loughlin AJ, Paemen L, Opdenakker G,
Newcombe J: The expression of tissue-type plasminogen activator,
matrix metalloproteases and endogenous inhibitors in the central
nervous system in multiple sclerosis: comparison of stages in lesion
evolution. J Neuropathol Exp Neurol 1996, 55:1194-1204.
16. Sarchielli P, Greco L, Floridi A, Floridi A, Gallai V: Excitatory amino acids
and multiple sclerosis: evidence from cerebrospinal fluid. Arch Neurol
2003, 60:1082-1088.
17. Bitsch A, Kuhlmann T, Da Costa C, Bunkowski S, Polak T, Bruck W: Tumour
necrosis factor alpha mRNA expression in early multiple sclerosis lesions:
correlation with demyelinating activity and oligodendrocyte pathology.
Glia 2000, 29:366-375.
18. Smith KJ, Lassmann H: The role of nitric oxide in multiple sclerosis. Lancet
Neurol 2002, 1:232-241.
19. Conrad DJ, Kuhn H, Mulkins M, Highland E, Sigal E: Specific inflammatory
cytokines regulate the expression of human monocyte 15-lipoxygenase.
Proc Natl Acad Sci USA 1992, 89:217-221.
Vereyken et al. Journal of Neuroinflammation 2011, 8:58
http://www.jneuroinflammation.com/content/8/1/58
Page 14 of 1620. Hendriks JJ, Teunissen CE, de Vries HE, Dijkstra CD: Macrophages and
neurodegeneration. Brain Res Brain Res Rev 2005, 48:185-195.
21. Selmaj KW, Raine CS: Tumor necrosis factor mediates myelin and
oligodendrocyte damage in vitro. Ann Neurol 1988, 23:339-346.
22. Newman TA, Woolley ST, Hughes PM, Sibson NR, Anthony DC, Perry VH: T-
cell- and macrophage-mediated axon damage in the absence of a CNS-
specific immune response: involvement of metalloproteinases. Brain
2001, 124:2203-2214.
23. Huitinga I, van Rooijen N, De Groot CJ, Uitdehaag BM, Dijkstra CD:
Suppression of experimental allergic encephalomyelitis in Lewis rats
after elimination of macrophages. J Exp Med 1990, 172:1025-1033.
24. Heppner FL, Greter M, Marino D, Falsig J, Raivich G, Hovelmeyer N,
Waisman A, Rulicke T, Prinz M, Priller J, Becher B, Aguzzi A: Experimental
autoimmune encephalomyelitis repressed by microglial paralysis. Nat
Med 2005, 11:146-152.
25. Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Bruck W: Acute axonal
injury in multiple sclerosis. Correlation with demyelination and
inflammation. Brain 2000, 123:1174-1183.
26. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Bruck W: Acute axonal
damage in multiple sclerosis is most extensive in early disease stages
and decreases over time. Brain 2002, 125:2202-2212.
27. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L: Axonal
transection in the lesions of multiple sclerosis. N Engl J Med 1998,
338:278-285.
28. Kotter MR, Li WW, Zhao C, Franklin RJ: Myelin impairs CNS remyelination
by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci
2006, 26:328-332.
29. Baer AS, Syed YA, Kang SU, Mitteregger D, Vig R, Ffrench-Constant C,
Franklin RJ, Altmann F, Lubec G, Kotter MR: Myelin-mediated inhibition of
oligodendrocyte precursor differentiation can be overcome by
pharmacological modulation of Fyn-RhoA and protein kinase C
signalling. Brain 2009, 132:465-481.
30. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE,
Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C,
Lassmann H, Wekerle H, Hohlfeld R: Activated human T cells, B cells, and
monocytes produce brain-derived neurotrophic factor in vitro and in
inflammatory brain lesions: a neuroprotective role of inflammation? J
Exp Med 1999, 189:865-870.
31. Stadelmann C, Kerschensteiner M, Misgeld T, Bruck W, Hohlfeld R,
Lassmann H: BDNF and gp145trkB in multiple sclerosis brain lesions:
neuroprotective interactions between immune and neuronal cells? Brain
2002, 125:75-85.
32. Kotter MR, Zhao C, van Rooijen N, Franklin RJ: Macrophage-depletion
induced impairment of experimental CNS remyelination is associated
with a reduced oligodendrocyte progenitor cell response and altered
growth factor expression. Neurobiol Dis 2005, 18:166-175.
33. Popovich PG, Guan Z, Wei P, Huitinga I, van Rooijen N, Stokes BT:
Depletion of hematogenous macrophages promotes partial hindlimb
recovery and neuroanatomical repair after experimental spinal cord
injury. Exp Neurol 1999, 158:351-365.
34. Stirling DP, Khodarahmi K, Liu J, McPhail LT, McBride CB, Steeves JD,
Ramer MS, Tetzlaff W: Minocycline treatment reduces delayed
oligodendrocyte death, attenuates axonal dieback, and improves
functional outcome after spinal cord injury. J Neurosci 2004, 24:2182-2190.
35. Iannotti CA, Clark M, Horn KP, van RN, Silver J, Steinmetz MP: A
combination immunomodulatory treatment promotes neuroprotection
and locomotor recovery after contusion SCI. Exp Neurol 2010.
36. Rapalino O, Lazarov-Spiegler O, Agranov E, Velan GJ, Yoles E, Fraidakis M,
Solomon A, Gepstein R, Katz A, Belkin M, Hadani M, Schwartz M:
Implantation of stimulated homologous macrophages results in partial
recovery of paraplegic rats. Nat Med 1998, 4:814-821.
37. Barrette B, Hebert MA, Filali M, Lafortune K, Vallieres N, Gowing G, Julien JP,
Lacroix S: Requirement of myeloid cells for axon regeneration. J Neurosci
2008, 28:9363-9376.
38. Prewitt CM, Niesman IR, Kane CJ, Houle JD: Activated macrophage/
microglial cells can promote the regeneration of sensory axons into the
injured spinal cord. Exp Neurol 1997, 148:433-443.
39. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG:
Identification of two distinct macrophage subsets with divergent effects
causing either neurotoxicity or regeneration in the injured mouse spinal
cord. J Neurosci 2009, 29:13435-13444.
40. Butovsky O, Ziv Y, Schwartz A, Landa G, Talpalar AE, Pluchino S, Martino G,
Schwartz M: Microglia activated by IL-4 or IFN-gamma differentially
induce neurogenesis and oligodendrogenesis from adult stem/
progenitor cells. Mol Cell Neurosci 2006, 31:149-160.
41. Ponomarev ED, Maresz K, Tan Y, Dittel BN: CNS-derived interleukin-4 is
essential for the regulation of autoimmune inflammation and induces a
state of alternative activation in microglial cells. J Neurosci 2007,
27:10714-10721.
42. Johnson CR, Kitz D, Little JR: A method for the derivation and continuous
propagation of cloned murine bone marrow macrophages. J Immunol
Methods 1983, 65:319-332.
43. Varin A, Mukhopadhyay S, Herbein G, Gordon S: Alternative activation of
macrophages by IL-4 impairs phagocytosis of pathogens but potentiates
microbial-induced signalling and cytokine secretion. Blood 2010,
115:353-362.
44. Maier O, van der Heide T, van Dam AM, Baron W, de Vries H, Hoekstra D:
Alteration of the extracellular matrix interferes with raft association of
neurofascin in oligodendrocytes. Potential significance for multiple
sclerosis. Mol Cell Neurosci 2005, 28:390-401.
45. Buttery PC, Ffrench-Constant C: Laminin-2/integrin interactions enhance
myelin membrane formation by oligodendrocytes. Mol Cell Neurosci 1999,
14:199-212.
46. Bos HJ, Boorsma DM, Tuk CW, de Veld JC, Van der Muysenberg AJ,
Helmerhorst TJ, Struijk DG, Van Bronswijk H, Beelen RH: Chemotaxis of the
peritoneal cells and the detection of a chemo-attractant in the effluent
from peritoneal dialysis patients. Eur J Clin Invest 1990, 20:555-562.
47. van der Goes A, Wouters D, van der Pol SM, Huizinga R, Ronken E,
Adamson P, Greenwood J, Dijkstra CD, de Vries HE: Reactive oxygen
species enhance the migration of monocytes across the blood-brain
barrier in vitro. FASEB J 2001, 15:1852-1854.
48. Heeroma JH, Roelandse M, Wierda K, van Aerde KI, Toonen RF,
Hensbroek RA, Brussaard A, Matus A, Verhage M: Trophic support delays
but does not prevent cell-intrinsic degeneration of neurons deficient for
munc18-1. Eur J Neurosci 2004, 20:623-634.
49. Pourshafie MR, Sonnenfeld G: Treatment of an infected murine
macrophage cell line (J774A.1) with interferon-gamma but not tumor
necrosis factor-alpha or live Mycobacterium intracellulare alone
modulates the expression of adhesion molecules. J Interferon Cytokine Res
1997, 17:69-75.
50. van der Laan LJ, Ruuls SR, Weber KS, Lodder IJ, Dopp EA, Dijkstra CD:
Macrophage phagocytosis of myelin in vitro determined by flow
cytometry: phagocytosis is mediated by CR3 and induces production of
tumor necrosis factor-alpha and nitric oxide. J Neuroimmunol 1996,
70:145-152.
51. van Zwam M, Huizinga R, Melief MJ, Wierenga-Wolf AF, van Meurs M,
Voerman JS, Biber KP, Boddeke HW, Hopken UE, Meisel C, Meisel A,
Bechmann I, Hintzen RQ, ’t Hart BA, Amor S, Laman JD, Boven LA: Brain
antigens in functionally distinct antigen-presenting cell populations in
cervical lymph nodes in MS and EAE. J Mol Med 2009, 87:273-286.
52. de Haas AH, van Weering HR, de Jong EK, Boddeke HW, Biber KP: Neuronal
chemokines: versatile messengers in central nervous system cell
interaction. Mol Neurobiol 2007, 36:137-151.
53. Gleichmann M, Gillen C, Czardybon M, Bosse F, Greiner-Petter R, Auer J,
Muller HW: Cloning and characterization of SDF-1gamma, a novel SDF-1
chemokine transcript with developmentally regulated expression in the
nervous system. Eur J Neurosci 2000, 12:1857-1866.
54. Martinez FO, Gordon S, Locati M, Mantovani A: Transcriptional profiling of
the human monocyte-to-macrophage differentiation and polarization:
new molecules and patterns of gene expression. J Immunol 2006,
177:7303-7311.
55. Wolswijk G: Oligodendrocyte precursor cells in the demyelinated
multiple sclerosis spinal cord. Brain 2002, 125:338-349.
56. Kotter MR, Setzu A, Sim FJ, van Rooijen N, Franklin RJ: Macrophage
depletion impairs oligodendrocyte remyelination following lysolecithin-
induced demyelination. Glia 2001, 35:204-212.
57. Schiffmann E: Leukocyte chemotaxis. Annu Rev Physiol 1982, 44:553-568.
58. Deshmane SL, Kremlev S, Amini S, Sawaya BE: Monocyte
chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine
Res 2009, 29:313-326.
59. Jee Y, Yoon WK, Okura Y, Tanuma N, Matsumoto Y: Upregulation of
monocyte chemotactic protein-1 and CC chemokine receptor 2 in the
Vereyken et al. Journal of Neuroinflammation 2011, 8:58
http://www.jneuroinflammation.com/content/8/1/58
Page 15 of 16central nervous system is closely associated with relapse of autoimmune
encephalomyelitis in Lewis rats. J Neuroimmunol 2002, 128:49-57.
60. Berman JW, Guida MP, Warren J, Amat J, Brosnan CF: Localization of
monocyte chemoattractant peptide-1 expression in the central nervous
system in experimental autoimmune encephalomyelitis and trauma in
the rat. J Immunol 1996, 156:3017-3023.
61. Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN: Expression of
monocyte chemoattractant protein-1 and other beta-chemokines by
resident glia and inflammatory cells in multiple sclerosis lesions. J
Neuroimmunol 1998, 84:238-249.
62. Ke H, Parron VI, Reece J, Zhang JY, Akiyama SK, French JE: BCL2 inhibits
cell adhesion, spreading, and motility by enhancing actin
polymerization. Cell Res 2010, 20:458-469.
63. Lochhead PA, Wickman G, Mezna M, Olson MF: Activating ROCK1 somatic
mutations in human cancer. Oncogene 2010, 29:2591-2598.
64. Varga G, Ehrchen J, Tsianakas A, Tenbrock K, Rattenholl A, Seeliger S,
Mack M, Roth J, Sunderkoetter C: Glucocorticoids induce an activated,
anti-inflammatory monocyte subset in mice that resembles myeloid-
derived suppressor cells. J Leukoc Biol 2008, 84:644-650.
65. Goebeler M, Roth J, Kunz M, Sorg C: Expression of intercellular adhesion
molecule-1 by murine macrophages is up-regulated during
differentiation and inflammatory activation. Immunobiology 1993,
188:159-171.
66. Verreck FA, de Boer T, Langenberg DM, van der Zanden L, Ottenhoff TH:
Phenotypic and functional profiling of human proinflammatory type-1
and anti-inflammatory type-2 macrophages in response to microbial
antigens and IFN-gamma- and CD40L-mediated costimulation. J Leukoc
Biol 2006, 79:285-293.
67. van der Laan LJ, Ruuls SR, Weber KS, Lodder IJ, Dopp EA, Dijkstra CD:
Macrophage phagocytosis of myelin in vitro determined by flow
cytometry: phagocytosis is mediated by CR3 and induces production of
tumor necrosis factor-alpha and nitric oxide. J Neuroimmunol 1996,
70:145-152.
68. van der Goes A, Brouwer J, Hoekstra K, Roos D, van den Berg TK,
Dijkstra CD: Reactive oxygen species are required for the phagocytosis of
myelin by macrophages. J Neuroimmunol 1998, 92:67-75.
69. Hendriks JJ, de Vries HE, van der Pol SM, Van Den Berg TK, van Tol EA,
Dijkstra CD: Flavonoids inhibit myelin phagocytosis by macrophages; a
structure-activity relationship study. Biochem Pharmacol 2003, 65:877-885.
70. Kim HK, Cheon BS, Kim YH, Kim SY, Kim HP: Effects of naturally occurring
flavonoids on nitric oxide production in the macrophage cell line RAW
264.7 and their structure-activity relationships. Biochem Pharmacol 1999,
58:759-765.
71. Wadsworth TL, Koop DR: Effects of the wine polyphenolics quercetin and
resveratrol on pro-inflammatory cytokine expression in RAW 264.7
macrophages. Biochem Pharmacol 1999, 57:941-949.
72. Hespanhol MR, Mantovani B: Phagocytosis by macrophages mediated by
receptors for denatured proteins - dependence on tyrosine protein
kinases. Braz J Med Biol Res 2002, 35:383-389.
73. Lee WJ, Wu LF, Chen WK, Wang CJ, Tseng TH: Inhibitory effect of luteolin
on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion
involving both MAPK/ERKs and PI3K-Akt pathways. Chem Biol Interact
2006, 160:123-133.
74. Lee JW, Ahn JY, Hasegawa S, Cha BY, Yonezawa T, Nagai K, Seo HJ,
Jeon WB, Woo JT: Inhibitory effect of luteolin on osteoclast
differentiation and function. Cytotechnology 2009, 61:125-134.
75. Hendriks JJ, Alblas J, van der Pol SM, van Tol EA, Dijkstra CD, de Vries HE:
Flavonoids influence monocytic GTPase activity and are protective in
experimental allergic encephalitis. J Exp Med 2004, 200:1667-1672.
76. Bjartmar C, Kidd G, Mork S, Rudick R, Trapp BD: Neurological disability
correlates with spinal cord axonal loss and reduced N-acetyl aspartate in
chronic multiple sclerosis patients. Ann Neurol 2000, 48:893-901.
77. Zheng D, Wang Y, Cao Q, Lee VW, Zheng G, Sun Y, Tan TK, Wang Y,
Alexander SI, Harris DC: Transfused Macrophages Ameliorate Pancreatic
and Renal Injury in Murine Diabetes Mellitus. Nephron Exp Nephrol 2011,
118:e87-e99.
78. Hunter MM, Wang A, Parhar KS, Johnston MJ, van RN, Beck PL, McKay DM:
In vitro-derived alternatively activated macrophages reduce colonic
inflammation in mice. Gastroenterology 2010, 138:1395-1405.
79. Busch SA, Hamilton JA, Horn KP, Cuascut FX, Cutrone R, Lehman N,
Deans RJ, Ting AE, Mays RW, Silver J: Multipotent adult progenitor cells
prevent macrophage-mediated axonal dieback and promote regrowth
after spinal cord injury. J Neurosci 2011, 31:944-953.
80. Dogan RN, Long N, Forde E, Dennis K, Kohm AP, Miller SD, Karpus WJ:
CCL22 regulates experimental autoimmune encephalomyelitis by
controlling inflammatory macrophage accumulation and effector
function. J Leukoc Biol 2011, 89:93-104.
81. Lourbopoulos A, Grigoriadis N, Lagoudaki R, Touloumi O, Polyzoidou E,
Mavromatis I, Tascos N, Breuer A, Ovadia H, Karussis D, Shohami E,
Mechoulam R, Simeonidou C: Administration of 2-arachidonoylglycerol
ameliorates both acute and chronic Experimental Autoimmune
Encephalomyelitis. Brain Res 2011, 1390:126-41.
82. Mikita J, Dubourdieu-Cassagno N, Deloire MS, Vekris A, Biran M, Raffard G,
Brochet B, Canron MH, Franconi JM, Boiziau C, Petry KG: Altered M1/M2
activation patterns of monocytes in severe relapsing experimental rat
model of Multiple Sclerosis. Amelioration of clinical status by M2
activated monocyte administration. Mult Scler 2011, 17(1):2-15.
83. Weber MS, Prod’homme T, Youssef S, Dunn SE, Rundle CD, Lee L,
Patarroyo JC, Stuve O, Sobel RA, Steinman L, Zamvil SS: Type II monocytes
modulate T cell-mediated central nervous system autoimmune disease.
Nat Med 2007, 13:935-943.
84. Christophi GP, Panos M, Hudson CA, Christophi RL, Gruber RC, Mersich AT,
Blystone SD, Jubelt B, Massa PT: Macrophages of multiple sclerosis
patients display deficient SHP-1 expression and enhanced inflammatory
phenotype. Lab Invest 2009, 89:742-759.
85. Christophi GP, Hudson CA, Gruber RC, Christophi CP, Mihai C, Mejico LJ,
Jubelt B, Massa PT: SHP-1 deficiency and increased inflammatory gene
expression in PBMCs of multiple sclerosis patients. Lab Invest 2008,
88:243-255.
86. Colton CA, Mott RT, Sharpe H, Xu Q, Van Nostrand WE, Vitek MP:
Expression profiles for macrophage alternative activation genes in AD
and in mouse models of AD. J Neuroinflammation 2006, 3:27.
doi:10.1186/1742-2094-8-58
Cite this article as: Vereyken et al.: Classically and alternatively activated
bone marrow derived macrophages differ in cytoskeletal functions and
migration towards specific CNS cell types. Journal of Neuroinflammation
2011 8:58.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Vereyken et al. Journal of Neuroinflammation 2011, 8:58
http://www.jneuroinflammation.com/content/8/1/58
Page 16 of 16